Fosun Wanbang (Jiangsu) Pharmaceutical Group is an innovation-driven pharmaceutical company in China and a core member of Fosun Pharma, with business spanning pharmaceutical R&D, manufacturing, wholesale and distribution across the healthcare industry chain. Several of its production lines have passed FDA and EU site audits, with key products including human insulins, GLP-1 products, EPO and heparin sodium, along with oral solid dosage products such as ticagrelor, tofacitinib, crizotinib and osimertinib tablets, and key APIs including insulins, heparin sodium, venetoclax and febuxostat.

댓글이 없습니다.
평가 & 댓글 남기기